TAK-559 and insulin
01-03-TL-559-016
Phase 3 small_molecule terminated
Quick answer
TAK-559 and insulin for Diabetes Mellitus is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Diabetes Mellitus
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated